Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $60.4M $41.1M $27.3M $16.8M $10.9M $7.7M $4.8M $3.0M
Cost of Revenue $9.3M $6.5M $4.8M $3.4M $2.4M $2.0M $2.4M $1.4M
Gross Profit $51.1M $34.6M $22.5M $13.4M $8.5M $5.7M $2.4M $1.6M
Gross Margin 84.6% 84.3% 82.3% 79.5% 77.7% 74.5% 50.0% 54.1%
Operating Expenses
Research & Development $6.7M $4.2M $3.2M $3.0M $2.1M $1.4M $697.4K $436.0K
SG&A Expense $14.7M $10.1M $8.4M $6.9M $5.7M $5.2M $4.3M $2.7M
Operating Income $-8.0M $-8.1M $-9.3M $-9.8M $-9.6M $-7.8M $-7.0M $-4.5M
Operating Margin -13.2% -19.8% -33.9% -58.3% -87.6% -101.4% -143.7% -149.2%
Interest Expense $2.2M $5.4M $4.0M $6.8M $4.8M $1.4M $1.1M $815.0K
Pretax Income $-14.6M $-10.2M $-9.2M
Income Tax Expense $0 $0 $0 $0 $0 $-738.2K
Net Income $-10.4M $-14.4M $-13.4M $-17.7M $-14.6M $-9.4M $-9.2M $-5.4M
Net Margin -17.3% -35.1% -48.9% -105.3% -133.0% -122.4% -190.1% -180.5%
EPS (Basic) $-0.31 $-0.47 $-0.51 $-0.99 $-1.08 $-0.85 $-2.77 $-8.35
EPS (Diluted) $-0.31 $-0.47 $-0.51 $-0.99 $-1.08 $-0.85 $-2.77 $-8.35
Shares Outstanding (Basic) 34.4M 33.0M 30.0M 19.5M 17.3M 11.1M 11.1M 1.2M
Shares Outstanding (Diluted) 34.4M 33.0M 30.0M 19.5M 17.3M 11.1M 11.1M 1.2M
Dividends Per Share
← Newer Page 2 of 2 Older →